Elevated plasma Complement Factor H Regulating Protein 5 is associated with venous thromboembolism and COVID-19 severity

Laura Sánchez‐Rivera(Science for Life Laboratory), Jacob Odeberg(Karolinska University Hospital), Alice Assinger(Medical University of Vienna), David M. Smadja(Sorbonne Paris Cité), Angela Silveira, Charlotte Thålin(Karolinska Institutet), Jochen M. Schwenk(KTH Royal Institute of Technology), Joseph Emmerich(Délégation Paris 5), Thomas Renné(University of Würzburg), José Manuel Soria, Marine Germain(Inserm), Maria Farm(Karolinska University Hospital), Sebastian Havervall(Karolinska Institutet), Margareta Holmström(Integrated Cardio Metabolic Centre), Jean‐François Deleuze(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Mathias Uhlén(University of California, Los Angeles), Ángel Martínez-Pérez(Sant Joan de Déu Research Foundation), Louisa Goumidi(Inserm), Anne Boland(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), David‐Alexandre Trégouët(Inserm), Juan Carlos Souto Andres(Hospital de Sant Pau), Pierre‐Emmanuel Morange(Aix-Marseille Université), María Jesús Iglesias(University Hospital of North Norway), Manal Ibrahim‐Kosta(Inserm), Maria Magnusson(Karolinska University Hospital), Philip B. Smith(Karolinska University Hospital), Julia B. Kral‐Pointner(Medical University of Vienna), Clément Naudin(Science for Life Laboratory), Gaëlle Munsch(Université de Bordeaux), Jovan P. Antović(Karolinska University Hospital), Pierre Suchon(Inserm), Mun‐Gwan Hong(Science for Life Laboratory), Lynn M. Butler(Karolinska University Hospital)
medRxiv
April 21, 2022
Cited by 2


Related Papers